Aura Biosciences, Inc. announced that it will receive $80,483,829 in funding on March 17, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.31 USD | -3.05% | -7.35% | -17.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.49% | 373M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it expects to receive $80.483829 million in funding